Health Technology Assessment International Symposium
Global Perspectives on Health Technology Assessment and Policy
—The Paths of the EU, the US, Asia, and Japan—
Date & Time: | Thursday, 6th of September, 2012, 10:30-17:40 |
---|---|
Venue: | Ito Hall, Ito International Research Center (Hongo Campus of The University of Tokyo) |
MAP(121KB, PDF) | |
Organizer: | Graduate School of Public Policy (GraSPP), The University of Tokyo |
Co-Sponsors: | Todai Policy Alternatives Research Institute |
The Canon Institute for Global Studies (CIGS) | |
Language: | English |
Simultaneous interpretation between English and Japanese will be provided. |
Program
10:30-10:40 | Opening Remarks |
---|---|
Takatoshi Ito, Dean, Graduate School of Public Policy, The University of Tokyo | |
Toshihiko Fukui, President of the Canon Institute for Global Studies | |
10:40-11:20 | Michael Drummond, Professor, The University of York |
“Key Principles for the Conduct of HTA for Resource Allocation Decisions” |
11:20-12:00 | François Meyer, Director, International Affirs, French National Authority for Health (HAS) |
---|---|
“Need for Economic Evaluation in French Healthcare—Structure and Role of HAS—” |
12:00-12:40 | Peter Kolominsky-Rabas, Professor & Director,, Center for Health Technology Assessment (HTA) and Public Health, University of Erlangen-Nuremberg, Germany |
---|---|
“Access to Real Innovations in Times of Budget Constraints: the Role of G-BA and IQWiG for HTA in Germany” |
12:40-13:30 | Lunch |
---|---|
13:30-14:30 | Panel Discussion “Current Situation and Future of HTA in USA & Europe” |
Panelist: M. Drummond F. Meyer P. Kolominsky-Rabas | |
Moderator: Isao Kamae, Project Professor, The University of Tokyo |
14:30-14:45 | Break |
---|---|
14:45-15:10 | Gordon Liu, Professor, Peking University Guanghua School of Management |
“Healthcare Reform and Current Situation of HTA in China” |
15:10-15:35 | Bong-Min Yang, Professor, Seoul National University |
---|---|
“HTA in Korea; Stakeholder Involvement and Challenges Ahead” |
15:35-16:00 | Hong Li, Group Director, GHEOR Emerging Markets, Japan, and Asia, Bristol-Myers Squibb |
---|---|
“Overview of Health Technology Assessment (HTA) from Asia Perspective” |
16:00-16:25 | Donald Yin, Associate Vice President & Head, Global Health Outcome, Merck & Co., Inc. |
---|---|
“Industry Perspective on the Globalization of Health Technology Assessment” |
16:25-16:45 | Yasunori Yoshida, Pharmaceutical Management Director, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare |
---|---|
“Towards the HTA Implementation by MHLW in 2014” |
16:45-17:35 | Panel Discussion “Current Situation and Future of HTA in Asia” |
---|---|
Panelist: B. Yang H. Li D. Yin | |
Moderator: I. Kamae |
17:35-17:40 | Closing Remarks |
---|---|
Hideaki Shiroyama, Director, Todai Policy Alternatives Research Institute |